Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:49 PM
Ignite Modification Date:
2025-12-24 @ 2:49 PM
NCT ID:
NCT01058759
Eligibility Criteria:
Inclusion Criteria:
* Signed informed consent
* Men and women aged 18 and older
* Locally Advanced or Metastatic Non-small Cell Lung Cancer stage IIIB/IV without any previous therapy
* Life expectancy at least 12 weeks
* EOCG performance \< 1
* Appropriate renal and hepatic function
* Appropriate Hematology
* No bleeding events within 4 weeks prior to randomization
* No indication for prophylactic or therapeutic anticoagulation therapy
* Appropriate methods of contraception (both: men and women) for women of childbearing potential negative urine pregnancy test within 7 day prior to randomization
* Capability for s.c. injection of Enoxaparin every 24 hrs
Exclusion Criteria:
* History of cancer other than NSCLC
* Known contraindication for Enoxaparin e.g. HIT,
* Known contraindication for Docetaxel, Cisplatin, Carboplatin or co-medication
* Participation in any other clinical trials within 30 days prior to randomization
* Any known medical condition that does not allow therapy according to study protocol
* Seizure disorder
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01058759
Study Brief:
Protocol Section:
NCT01058759